Cesar Rodriguez

2.0k citations
22 papers · 334 indexed · h-index 9
Topics
Multiple Myeloma Research and Treatments (17 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)CAR-T cell therapy research (5 papers)

In The Last Decade

Cesar Rodriguez

21 papers receiving 324 citations

Peers

Cesar Rodriguez
Comparison fields: 5 of 49
  • Hematology 217
  • Oncology 190
  • Molecular Biology 119
  • Radiology, Nuclear Medicine and Imaging 107
  • Immunology 55
Replace Keqin Qi with:
Keqin Qi United States
Martine Poelman Belgium
Federica Cocito Italy
Tiffany Lin United States
Frank G. Basile United States
Syed Osman Ahmed Saudi Arabia
Zitong Chen China
Adir Shaulov Israel
Anna Pieczonka Poland
Mahmoud Sarhan Jordan
Cesar Rodriguez relative to Keqin Qi United States Keqin Qi's profile →
Citations per field
00.5×
Keqin Qi · 1×
Citations per year

Countries citing papers authored by Cesar Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Cesar Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesar Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesar Rodriguez more than expected).

Fields of papers citing papers by Cesar Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesar Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesar Rodriguez. The network helps show where Cesar Rodriguez may publish in the future.

Co-authorship network of co-authors of Cesar Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Cesar Rodriguez. A scholar is included among the top collaborators of Cesar Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesar Rodriguez. Cesar Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 1
3 84
4 20
5 2
6 4
7 36
8 3
9 18
10 0
11 10
12 1
13 45
14 32
15 1
16 2
17 3
18 3
19 44
20 1

About Cesar Rodriguez

Cesar Rodriguez is a scholar working on Hematology, Oncology and Transplantation, having authored 22 papers that have together received 334 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (217 citations), Oncology (190 citations) and Radiology, Nuclear Medicine and Imaging (107 citations). Cesar Rodriguez has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Peter M. Voorhees, Anita D’Souza, Ben Buelow, Ravi Vij, Nina Shah, Shaji Kumar, Orlando F. Bueno, Akshanth R. Polepally, Kevin J. Freise and Barry Paul. Their work appears in journals such as Journal of Clinical Oncology, Blood and Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026